Valuation (59%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 66.37 | 25.05 |
PEG Ratio (TTM) | 0.59 | -0.39 |
P/S Ratio (TTM) | 3.06 | 1.45 |
P/B Ratio (TTM) | 0.48 | 0.95 |
P/FCF Ratio (TTM) | 121.98 | 46.10 |
Price to 5YR AVG Earnings Ratio | 3.74 | 6.01 |
Price to 5YR AVG FCF Ratio | 39.70 | 17.24 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.36% | 3.98% |
ROE (TTM) | 0.69% | 6.21% |
Net Profit Margin (TTM) | 0.46% | 4.11% |
ROIC 5YR AVG | 23.34% | 20.33% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -13.55% | 121.39% | 49.77% |
Revenue | -3.86% | 19.63% | 13.64% |
Net Income | -12.97% | 122.26% | 50.25% |
Cash Flow | -14.62% | 17.88% | 9.46% |
Health (77%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.91 | 2.58 |
Quick Ratio (TTM) | 1.67 | 1.47 |
D/E Ratio (TTM) | 0.18 | 0.28 |
Interest Coverage (TTM) | 8.60 | 23.71 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 5.77 | 4.09 |
LTL to 5YR AVG FCF | 0.97 | 2.25 |
Shares Outstanding Growth 5YR AVG | N/A | -3.69% |